Closing the gap: Increases in life expectancy among treated HIV-positive individuals in the United States and Canada

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Samji, Hasina ^a   Cescon, Angela ^a   Hogg, Robert S ^a,b   Modur, Sharada P ^c   Althoff, Keri N ^c   Buchacz, Kate ^d   Burchell, Ann N ^e   Cohen, Mardge ^f   Gebo, Kelly A ^c   Gill, M John ^g   Justice, Amy ^h   Kirk, Gregory ^c   Klein, Marina B ⁱ   Korthuis, P Todd ^j   Martin, Jeff ^k   Napravnik, Sonia ^l   Rourke, Sean B ^e   Sterling, Timothy R ^m   Silverberg, Michael J ⁿ   Deeks, Stephen ^k   Jacobson, Lisa P ^c   Bosch, Ronald J ^o   Kitahata, Mari M ^p   Goedert, James J ^q   Moore, Richard ^c   Gange, Stephen J ^c   more..

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e ONTARIO HIV TREATMENT NETWORK   (Canada)

^f Bureau of Health Services of Cook County   (United States)

^g UNIVERSITY OF CALGARY   (Canada)

^h YALE UNIVERSITY   (United States)

ⁱ MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l UNIVERSITY OF NORTH CAROLINA   (United States)

^m VANDERBILT UNIVERSITY   (United States)

ⁿ KAISER PERMANENTE   (United States)

^o HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^p UNIVERSITY OF WASHINGTON   (United States)

^q NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ANTIVIRAL THERAPY; ARTICLE; CANADA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIFE EXPECTANCY; LIFE EXTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES; VIRUS TRANSMISSION; YOUNG ADULT;

ADULT; CANADA; FEMALE; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84893164523     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081355     Document Type: Article

References (31)

1. Boyd MA (2009) Improvements in antiretroviral therapy outcomes over calendar time. Curr Opin HIV AIDS 4: 194-199.
2. ART Cohort Collaboration 2008 Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372: 293.
3. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society-USA Panel. JAMA 308: 387-402.
4. Wood E, Kerr T, Marshall BDL, Li K, Zhang R, et al. (2009) Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ 338: b1649.
5. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 376: 532-539.
6. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, et al. (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493-505.
7. Justice AC (2010) HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep 7: 69-76.
8. Deeks SG (2011) HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 62: 141-155.
9. Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, et al. (2011) Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 155: 209-216.
10. Losina E, Schackman BR, Sadownik SN, Gebo KA, Walensky RP, et al. (2009) Racial and sex disparities in life expectancy losses among HIV-infected persons in the United States: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy. Clin Infect Dis 49: 1570-1578.
11. Palella Jr FJ, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, et al. (2011) Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment. AIDS 25: 1865-1876.
12. World Health Organization (2012) Life tables for WHO Member States. Available: http://www.who.int/healthinfo/statistics/mortality-life-tables/en/. Accessed 18 December 2012.
13. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, et al. (2007) Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 36: 294-301. (Pubitemid 47064328)
14. Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, et al. (2009) The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr 50: 529-536.
15. Chiang CL (1968) The life table and its construction. Introduction to Stochastic Processes in Biostatistics. New York: John Wiley and Sons. pp. 189-214.
16. Bor J, Herbst AJ, Newell ML, Bärnighausen T (2013) Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 339: 961-5.
17. World Health Organization (2013) Life Expectancy. Available: www.who.int/topics/life-expectancy/en/. Accessed: 30 September 2013.
18. Miniño AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: Final Data for 2008. National Vital Statistics Reports 59.
19. Robins JM, Finkelstein DM (2004) Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 56: 779-788.
20. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, et al. (2008) Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 148: 728-736. (Pubitemid 351717418)
21. Marmot M (2005) Social determinants of health inequalities. Lancet 365: 1099-1104.
22. Nakagawa F, May M, Phillips A (2013) Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 26: 17-25.
23. Wada N, Jacobson LP, Cohen M, French A, Phair J, et al. (2013) Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 177:116-25.
24. King JT, Justice AC, Roberts MS, Chang CCH, Fusco JS (2003) Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era. Med Decis Making 23: 9-20. (Pubitemid 36133356)
25. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, et al. (2007) Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 21: 685-692. (Pubitemid 46568625)
26. Simard EP, Fransua M, Naishadham D, Jemal A (2012) The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med 172: 1591-8.
27. Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, et al. (2006) Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia. AIDS 20: 445-450.
28. Wolfe D, Carrieri MP, Shepard D (2010) Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 376: 355-366.
29. Rubin MS, Colen CG, Link BG (2010) Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. Am J Public Health 100: 1053-1059.
30. DHHS: Panel on Antiretroviral Guidelines for Adults and Adolescents (2012) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available: aidsinfo.nih.gov/contentfiles/lvguidelines/. Accessed: 17 October 2012.
31. Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, et al. (2012) US trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med 157: 325-335.